Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Safety and efficacy of elranatamab + nirogacestat in patients with relapsed or refractory multiple myeloma: Results from the Phase 1b MagnetisMM-4 study

Ola Landgren, Suzanne Trudel, Jacalyn Rosenblatt, Arleigh McCurdy, Sumit Madan, Syed Abbas Ali, Nizar Bahlis, Eli Gabayan, Robert Vescio, Melissa O'Gorman, Shinta Cheng, Sibo Jiang, Margaret Hoyle, Jay Cheng, Erik Vandendries, Noopur Raje

Blood (2025) 146 (Supplement 1): 4058.

https://doi.org/10.1182/blood-2025-4058

Published: 2025

Journal Articles

Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial

Attaya Suvannasankha, Jonathan Kaufman, Ashraf Badros, Michel Pavic, Hock Choong Lai, Muhammad S. Raza, Parth S. Shah, Patrick Mueller, Jorge Acosta, Margaret Hoyle, Erik Vandendries, Jay Cheng, Alexander Lesokhin

Blood (2025) 146 (Supplement 1): 100.

https://doi.org/10.1182/blood-2025-100

Published: 2025